Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas linked to neurofibromatosis type 1.
• Reduced TP53 expression and epidermal growth factor receptor (EGFR) amplification are implicated in MPNST development.

Purpose of the Study:

• To investigate the cooperative effects of reduced TP53 expression and EGFR overexpression in Schwann cell transformation and MPNST formation.
• To elucidate the molecular mechanisms underlying MPNST tumorigenesis.

Main Methods:

• In vitro studies using immortalized human Schwann cells (HSC1λ) with modulated TP53 and EGFR expression.
• In vivo studies using transgenic mice with Trp53-null alleles and EGFR overexpression in Schwann cells.
• Tumor histological analysis and array comparative genome hybridization (aCGH).

Main Results:

• Concurrent TP53 and EGFR modulation enhanced HSC1λ cell proliferation and anchorage-independent growth.
• Transgenic mice exhibited increased neurofibroma and MPNST formation compared to controls.
• MPNSTs showed increased pAkt expression and specific chromosomal gains enriched in ERK5 signaling genes.

Conclusions:

• Altered p53 expression cooperates with EGFR overexpression to promote Schwann cell oncogenesis in vitro.
• This genetic cooperation drives MPNST tumorigenesis and progression in vivo.
• EGFR and TP53 alterations are key drivers in MPNST development.